title: [Prostate cancer test and medical reimbursement].
abstract: Until now there have been three diagnostic tests, prostate specific antigen (PSA, total PSA), gamma-seminoprotein (gamma-Sm), and prostate acid phosphatase (PAP), for prostate cancer. Recent progresses in utilization of PSA has resulted in two advanced tests, PSA-alpha 1 antichymotrypsin complex (PSA-ACT) and free PSA/total PSA ratio. Payment of each test ranges from 210 to 320 yen. The same as for other cancer tests, three tests is paid 440 yen, and four or more is paid 590 yen. To determine the cost effective choice, it is necessary to consult with appropriate urologists.
authors.affiliation: Department of Clinical Pathology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo 113-8421.
authors.forename: T
authors.initials: T
authors.lastname: Yamada
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D003950:Diagnostic Techniques, Urological / Q000191:economics*; D006801:Humans; D008297:Male; D009313:National Health Programs; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000191:economics*; D012051:Reimbursement Mechanisms
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen